Neuropathological studies of brains from patients with Alzheimer's disease (AD) have led to the hypothesis that the olfactory system is the initial site of involvement of the Alzheimer's disease process. In contrast to the auditory, visual, somatosensory, and motor pathways, significant numbers of neurofibrillary tangles are found in the olfactory pathways of AD brains, particularly regions receiving direct projections from the olfactory bulb, including the uncus the medial amygdaloid nuclei, and the prepyriform, pyriform, and entorhinal cortices. . Such observations, along with recent data demonstrating (a) olfactory dysfunction in many AD patients and (b) transport of viruses and other substances from the nasal cavity into the brain via the olfactory fila, suggest that substances etiologically associated with AD may be transported from the nasal cavity directly into the brain by the primary olfactory neurons. Parkinson's disease (PD) is also accompanied by odor identification and detection deficits similar to those observed in AD. However, neuropathological studies of PD olfactory pathways analogous to those performed on AD pathways have not been made. Furthermore, past studies of olfactory function in PD, as well as in AD, were performed mainly on patients who have been symptomatic for over a year and only a few types of olfactory tests were administered. Clearly, very early comprehensive testing is needed to establish the nature and time of onset of the olfactory disorders associated with AD and PD, as well as possible differences between them. Comprehensive longitudinal of factory testing of very early AD and PD patients will be performed in Experiment 1 to address these needs. The test results from the AD and PD patient groups will be compared to one another and to those from an age-, gender-, and race-matched normal control group. It will be determined whether the test scores correlate with levels of selected neurotransmitter metabolites obtained from a sample of lumbar CSF, as well as with basic neuropsychological measures of cognitive function. Experiment 2 will focus on relatively old AD and PD patients with, at most, mild dementia (to allow valid ante-mortem sensory testing). Relationships will be determined between (a) ante-mortem neuropsychological, behavioral, and sensory measures and (b) post-mortem neuropathological and neurochemical measures, including levels of serotonin, norepinephrine, dopamine, somatostatin, and acetylcholine present in selected brain regions. Close attention will be paid to the topographic distribution and degree of morphological and/or neurotransmitter alterations in different parts of the brain, with an em- phasis on olfactory-related structures. This research will yield basic information about the olfactory dysfunction that accompanies AD and PD and how these alterations relate to anatomical and neurochemical changes associated

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG008148-03
Application #
3119606
Study Section
Sensory Disorders and Language Study Section (CMS)
Project Start
1989-07-01
Project End
1992-12-31
Budget Start
1991-07-15
Budget End
1992-12-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sharer, James D; Leon-Sarmiento, Fidias E; Morley, James F et al. (2015) Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking. Mov Disord 30:859-62
Doty, Richard L; Bayona, Edgardo A; Leon-Ariza, Daniel S et al. (2014) The lateralized smell test for detecting Alzheimer's disease: failure to replicate. J Neurol Sci 340:170-3
Moberg, P J; Doty, R L (1997) Olfactory function in Huntington's disease patients and at-risk offspring. Int J Neurosci 89:133-9
McKeown, D A; Doty, R L; Perl, D P et al. (1996) Olfactory function in young adolescents with Down's syndrome. J Neurol Neurosurg Psychiatry 61:412-4
Doty, R L; McKeown, D A; Lee, W W et al. (1995) A study of the test-retest reliability of ten olfactory tests. Chem Senses 20:645-56
Doty, R L; Smith, R; McKeown, D A et al. (1994) Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Percept Psychophys 56:701-7
Stern, M B; Doty, R L; Dotti, M et al. (1994) Olfactory function in Parkinson's disease subtypes. Neurology 44:266-8
Lanza, D C; Deems, D A; Doty, R L et al. (1994) The effect of human olfactory biopsy on olfaction: a preliminary report. Laryngoscope 104:837-40
Doty, R L; Golbe, L I; McKeown, D A et al. (1993) Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43:962-5
Lanza, D C; Moran, D T; Doty, R L et al. (1993) Endoscopic human olfactory biopsy technique: a preliminary report. Laryngoscope 103:815-9

Showing the most recent 10 out of 17 publications